Newsroom Newsroom Press Releases Events & Presentations News Articles Media Center Recent Press Releases May 8, 2023 Frontier Medicines Announces Appointment of Andrew Krivoshik, M.D., Ph.D., as Chief Medical Officer View Release April 16, 2023 Frontier Medicines Presents New Preclinical Data on its Development Candidate, FMC-376, a Dual KRASG12C Inhibitor, at the 2023 AACR Annual Meeting View Release March 14, 2023 Frontier Medicines to Spotlight Lead Candidate, Novel Dual KRASG12C Inhibitor FMC-376, and the Frontier™ Platform at the 2023 AACR Annual Meeting View Release Read All Press Releases Events & Presentations UPCOMING EVENTS There are currently no upcoming events scheduled Select Media Coverage May 12, 2023 Fierce Biotech: Chutes & Ladders - Former Astellas development head jumps to new Frontier Read Article May 12, 2023 Endpoints News: Astellas president jumps to a new Frontier Read Article May 4, 2023 Fierce Biotech: Next round of KRAS drugs stretch for their 4-minute mile in the footsteps of Amgen and Mirati Read Article Read All News Media Center Media Contact Contact PR Team Logos Click on the links below to download a high resolution image of the Frontier Medicines logo Download Image Download Image Download Image Download Image
May 8, 2023 Frontier Medicines Announces Appointment of Andrew Krivoshik, M.D., Ph.D., as Chief Medical Officer View Release
April 16, 2023 Frontier Medicines Presents New Preclinical Data on its Development Candidate, FMC-376, a Dual KRASG12C Inhibitor, at the 2023 AACR Annual Meeting View Release
March 14, 2023 Frontier Medicines to Spotlight Lead Candidate, Novel Dual KRASG12C Inhibitor FMC-376, and the Frontier™ Platform at the 2023 AACR Annual Meeting View Release
May 12, 2023 Fierce Biotech: Chutes & Ladders - Former Astellas development head jumps to new Frontier Read Article
May 4, 2023 Fierce Biotech: Next round of KRAS drugs stretch for their 4-minute mile in the footsteps of Amgen and Mirati Read Article